Description
The main objective of the Action is to increase knowledge and understanding of the design and mechanisms of actions of metallo-drugs, and to use this enhanced knowledge in combination with modern genomic research to develop new classes of metallo-drugs with truly novel mechanisms of action and novel spectra of biomedical activity.
Action keywords
Parties
Action Leadership Positions
| Role | Leader |
|---|---|
| Action Chair | |
| Action Vice-Chair |
Management Committee
| Country | MC Member |
|---|---|
| Austria | |
| Belgium | |
| Denmark | |
| Denmark | |
| Denmark | |
| France | |
| France | |
| Germany | |
| Germany | |
| Germany | |
| Greece | |
| Hungary | |
| Hungary | |
| Ireland | |
| Ireland | |
| Italy | |
| Italy | |
| Netherlands | |
| Norway | |
| Norway | |
| Poland | |
| Portugal | |
| Romania | |
| Romania | |
| Serbia | |
| Serbia | |
| Slovenia | |
| Slovenia | |
| Spain | |
| Sweden | |
| Switzerland | |
| Switzerland | |
| Türkiye | |
| Türkiye | |
| United Kingdom | |
| United Kingdom |
| Country | MC Substitute |
|---|---|
| France | |
| Ireland | |
| Ireland | |
| Slovenia | |
| Slovenia |
Main Contacts
